Thymosin alpha 1 and anakirna, two naturally occurring immunomodulators, have demonstrated anti-inflammatory properties in CF models by reducing pro-inflammatory cytokines and improving CFTR stability [111,112,113,114]. Here, CFTR is linked to cystic fibrosis.